EU5 Insulin Delivery Market Outlook to 2025

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: April 30, 2020 Report Code: GDMECR1339DB-ST

Select Item

GlobalData’s “EU5 Insulin Delivery Market Outlook to 2025” is a comprehensive databook report, covering key market data on the EU5 Insulin Delivery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Insulin Pens and Insulin Pumps.

The EU5 Insulin Delivery Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2019 company share and distribution share data for Insulin Delivery Market.
• Global corporate-level profiles of key companies operating within the EU5 Insulin Delivery Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

EU5 Insulin Delivery Tests is segmented as follows:

• Insulin Pens and Insulin Pumps

Reasons to Buy

Key Reasons to Purchase – The EU5 Insulin Delivery Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “EU5 Insulin Delivery Market Outlook to 2025” report:
• Novo Nordisk AS
• Sanofi
• Eli Lilly and Co

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Insulin Delivery Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 9

3 Insulin Delivery Market, EU5 10

3.1 Insulin Delivery Market, EU5, Revenue ($m), 2015-2025 10

3.2 Insulin Delivery Market, EU5, Revenue ($m), 2015-2025 12

3.3 Insulin Delivery Market, EU5, Volume (Units), 2015-2025 14

3.4 Insulin Delivery Market, EU5, Volume (Units), 2015-2025 16

3.5 Insulin Delivery Market, EU5, Company Share by Revenue ($m), 2019 18

4 Insulin Delivery Market, France 20

4.1 Insulin Delivery Market, France, Revenue ($m), 2015-2025 20

4.1.1 Insulin Pens Market, France, Revenue ($m), by Segment, 2015-2025 22

4.1.2 Insulin Pumps Market, France, Revenue ($m), by Segment, 2015-2025 24

4.2 Insulin Delivery Market, France, Volume (Units), 2015-2025 26

4.2.1 Insulin Pens Market, France, Volume (Units), by Segment, 2015-2025 28

4.2.2 Insulin Pumps Market, France, Volume (Units), by Segment, 2015-2025 30

4.3 Insulin Delivery Market, France, Average Price ($), 2015-2025 32

4.4 Insulin Delivery Market, France, Distribution Share by Revenue ($m), 2019 33

4.5 Insulin Delivery Market, France, Company Share by Revenue ($m), 2019 34

5 Insulin Delivery Market, Germany 36

5.1 Insulin Delivery Market, Germany, Revenue ($m), 2015-2025 36

5.1.1 Insulin Pens Market, Germany, Revenue ($m), by Segment, 2015-2025 38

5.1.2 Insulin Pumps Market, Germany, Revenue ($m), by Segment, 2015-2025 40

5.2 Insulin Delivery Market, Germany, Volume (Units), 2015-2025 42

5.2.1 Insulin Pens Market, Germany, Volume (Units), by Segment, 2015-2025 44

5.2.2 Insulin Pumps Market, Germany, Volume (Units), by Segment, 2015-2025 46

5.3 Insulin Delivery Market, Germany, Average Price ($), 2015-2025 48

5.4 Insulin Delivery Market, Germany, Distribution Share by Revenue ($m), 2019 49

5.5 Insulin Delivery Market, Germany, Company Share by Revenue ($m), 2019 50

6 Insulin Delivery Market, Italy 52

6.1 Insulin Delivery Market, Italy, Revenue ($m), 2015-2025 52

6.1.1 Insulin Pens Market, Italy, Revenue ($m), by Segment, 2015-2025 54

6.1.2 Insulin Pumps Market, Italy, Revenue ($m), by Segment, 2015-2025 56

6.2 Insulin Delivery Market, Italy, Volume (Units), 2015-2025 58

6.2.1 Insulin Pens Market, Italy, Volume (Units), by Segment, 2015-2025 60

6.2.2 Insulin Pumps Market, Italy, Volume (Units), by Segment, 2015-2025 62

6.3 Insulin Delivery Market, Italy, Average Price ($), 2015-2025 64

6.4 Insulin Delivery Market, Italy, Distribution Share by Revenue ($m), 2019 65

6.5 Insulin Delivery Market, Italy, Company Share by Revenue ($m), 2019 66

7 Insulin Delivery Market, Spain 68

7.1 Insulin Delivery Market, Spain, Revenue ($m), 2015-2025 68

7.1.1 Insulin Pens Market, Spain, Revenue ($m), by Segment, 2015-2025 70

7.1.2 Insulin Pumps Market, Spain, Revenue ($m), by Segment, 2015-2025 72

7.2 Insulin Delivery Market, Spain, Volume (Units), 2015-2025 74

7.2.1 Insulin Pens Market, Spain, Volume (Units), by Segment, 2015-2025 76

7.2.2 Insulin Pumps Market, Spain, Volume (Units), by Segment, 2015-2025 78

7.3 Insulin Delivery Market, Spain, Average Price ($), 2015-2025 80

7.4 Insulin Delivery Market, Spain, Distribution Share by Revenue ($m), 2019 81

7.5 Insulin Delivery Market, Spain, Company Share by Revenue ($m), 2019 82

8 Insulin Delivery Market, United Kingdom 84

8.1 Insulin Delivery Market, United Kingdom, Revenue ($m), 2015-2025 84

8.1.1 Insulin Pens Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 86

8.1.2 Insulin Pumps Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 88

8.2 Insulin Delivery Market, United Kingdom, Volume (Units), 2015-2025 90

8.2.1 Insulin Pens Market, United Kingdom, Volume (Units), by Segment, 2015-2025 92

8.2.2 Insulin Pumps Market, United Kingdom, Volume (Units), by Segment, 2015-2025 94

8.3 Insulin Delivery Market, United Kingdom, Average Price ($), 2015-2025 96

8.4 Insulin Delivery Market, United Kingdom, Distribution Share by Revenue ($m), 2019 97

8.5 Insulin Delivery Market, United Kingdom, Company Share by Revenue ($m), 2019 98

9 Overview of Key Companies in EU5 Insulin Delivery Market 100

9.1 Novo Nordisk AS 100

9.1.1 Company Overview 100

9.2 Sanofi 100

9.2.1 Company Overview 100

9.3 Eli Lilly and Co 100

9.3.1 Company Overview 100

9.4 Medtronic Plc 101

9.4.1 Company Overview 101

9.5 Ypsomed Holding AG 101

9.5.1 Company Overview 101

9.6 F. Hoffmann-La Roche Ltd 101

9.6.1 Company Overview 101

10 Insulin Delivery Market Pipeline Products 102

11 Recent Developments 104

11.1 Corporate Communications 104

11.1.1 Feb 27, 2020: ConvaTec Group: Non-executive director appointment 104

11.1.2 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer 104

11.1.3 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer 105

11.1.4 Feb 22, 2020: Bayer Cares Foundation donates over EUR 363,000 to support 94 social projects in 32 countries worldwide 105

11.1.5 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 105

11.1.6 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 106

11.1.7 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 107

11.1.8 Sep 10, 2019: Bayer reduces size of board of management from seven to five members 108

11.1.9 Sep 09, 2019: Midatech Pharma announces directorate change 109

11.1.10 Sep 03, 2019: Bayer appoints Marianne De Backer Head of Pharmaceuticals Business Development & Licensing and Member of Executive Committee 109

11.1.11 Aug 28, 2019: Medtronic announces planned leadership succession 110

11.1.12 Aug 19, 2019: John McAdam appointed Chairman of ConvaTec 112

11.1.13 Jul 31, 2019: Midatech Pharma: Appointment of Non-Executive Director 112

11.1.14 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 113

11.1.15 Jun 25, 2019: ConvaTec Group: Board Change 114

11.1.16 Jun 07, 2019: Jubilant DraxImage receives CE Mark certificate for its medical device RUBY Rubidium Elution System (RbES) and Proprietary RUBY 114

Consumable Accessories 114

11.1.17 Apr 16, 2019: Ginkgo Bioworks appoints former Bayer CEO Marijn Dekkers as Chairman of its Board of Directors 115

11.1.18 Apr 12, 2019: Dr. Monika Lessl to lead both the Bayer Science and the Bayer Cares Foundations 116

11.2 Financial Announcements 117

11.2.1 Feb 28, 2020: ConvaTec Group: Audited annual results for the twelve months ended 31 December 2019 117

11.2.2 Feb 18, 2020: Medtronic reports third quarter financial results 2020 118

11.2.3 Feb 05, 2020: Novo Nordisk's operating profit increased by 11% in Danish kroner and by 6% at constant exchange rates (CER) in 2019 120

11.2.4 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 121

11.2.5 Nov 05, 2019: Ypsomed grows strongly in the pen business 123

11.2.6 Nov 01, 2019: Novo Nordisk's operating profit increased by 11% in Danish kroner and by 5% at constant exchange rates (CER) in the first nine months of 2019 125

11.2.7 Sep 30, 2019: Midatech Pharma: Interim results for the six months ended 30 June 2019 126

11.2.8 Aug 20, 2019: Medtronic reports first quarter financial results for 2019 131

11.2.9 Aug 08, 2019: Novo Nordisk's operating profit increased by 12% in Danish kroner and by 6% at constant exchange rates (CER) in the first six months of 2019 133

11.2.10 Aug 01, 2019: ConvaTec Group first half results 2019 134

11.2.11 Jul 30, 2019: Bayer on track in operational business 140

11.2.12 May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results 143

11.2.13 May 20, 2019: Ayala Pharmaceuticals to present at ASCO Annual Meeting on investigational drug AL101 in adenoid cystic carcinoma and triple negative breast cancer 145

11.2.14 May 03, 2019: Novo Nordisk's operating profit increased by 14% in Danish kroner and by 8% at constant exchange rates (CER) in the first three months of 2019 147

11.2.15 Apr 24, 2019: Midatech Pharma: Audited financial results for the year ended 31 December 2018 148

11.3 Legal And Regulatory 149

11.3.1 Oct 03, 2019: Lilly announces voluntary delisting from Euronext Paris 149

11.3.2 Sep 30, 2019: Adocia announces receipt of USD

14.3 million payment from Eli Lilly following arbitration conclusion and the decision by mutual consent with Eli Lilly to conclude the civil case 150

11.3.3 Aug 23, 2019: Adocia announces that the American Arbitration Association Tribunal Dismissed all Claims in Second Phase of Arbitration With Eli Lilly 150

11.3.4 Aug 16, 2019: Novo Nordisk: Securities lawsuit filed in Denmark against Novo Nordisk 151

11.4 Other Significant Developments 151

11.4.1 Feb 27, 2020: Bayer reaches agreement with stockholder Prof. Strenger on voluntary special audit of due diligence procedures 151

11.4.2 Dec 10, 2019: Bayer to significantly step-up its sustainability efforts 152

11.4.3 Oct 21, 2019: CRISPR Therapeutics and Bayer announce an update on Casebia Therapeutics 154

11.4.4 Oct 10, 2019: clayton cuts ribbon on historic biopharma infrastructure 154

11.4.5 Sep 06, 2019: Novo Nordisk to provide discounted insulin products in US 155

11.4.6 Jun 19, 2019: Gamida Cell and Lonza establish commercial manufacturing agreement for omidubicel 156

11.4.7 May 23, 2019: Ypsomed increases EBIT and invests in long-term profitability 157

11.4.8 Apr 30, 2019: Novo Nordisk to achieve target of 100% renewable power in production and launches new ambition aiming for zero environmental impact 159

11.4.9 Apr 25, 2019: Bayer: strong operational start to the year 160

11.5 Strategy And Business Planning 162

11.5.1 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe 162

11.5.2 Aug 30, 2019: Ypsomed expands headquarters in Burgdorf 163

11.5.3 Aug 22, 2019: Ypsomed opens production plant in Schwerin 163

12 Appendix 165

12.1 Research Methodology 166

12.1.1 Coverage 166

12.1.2 Secondary Research 166

12.1.3 Primary Research 167

12.1.4 Market Modeling and Forecasting 168

12.1.5 Company Share Analysis 169

12.1.6 Distribution Share Analysis 169

12.1.7 Benchmarking 170

12.2 GlobalData Consulting 170

12.3 Contact Us 171

12.4 Disclaimer 171

Table

1.1 List of Tables

Table 1: Insulin Delivery Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2015-2025 11

Table 2: Insulin Delivery Market, EU5, Revenue ($m), Historic, USD Constant, 2015-2020 13

Table 3: Insulin Delivery Market, EU5, Revenue ($m), Forecast, USD Constant, 2021-2025 13

Table 4: Insulin Delivery Market, EU5, Volume (Units), 2015-2025 15

Table 5: Insulin Delivery Market, EU5, Volume (Units), 2015-2020 17

Table 6: Insulin Delivery Market, EU5, Volume (Units), 2021-2025 17

Table 7: Insulin Delivery Market, EU5, Company Share by Revenue ($m), USD Constant, 2019 19

Table 8: Insulin Delivery Market, France, Revenue ($m), USD Constant, 2015-2020 21

Table 9: Insulin Delivery Market, France, Revenue ($m), USD Constant, 2021-2025 21

Table 10: Insulin Pens Market, France, Revenue ($m), USD Constant, 2015-2020 23

Table 11: Insulin Pens Market, France, Revenue ($m), USD Constant, 2021-2025 23

Table 12: Insulin Pumps Market, France, Revenue ($m), USD Constant, 2015-2020 25

Table 13: Insulin Pumps Market, France, Revenue ($m), USD Constant, 2021-2025 25

Table 14: Insulin Delivery Market, France, Volume (Units), 2015-2020 27

Table 15: Insulin Delivery Market, France, Volume (Units), 2021-2025 27

Table 16: Insulin Pens Market, France, Volume (Units), 2015-2020 29

Table 17: Insulin Pens Market, France, Volume (Units), 2021-2025 29

Table 18: Insulin Pumps Market, France, Volume (Units), 2015-2020 31

Table 19: Insulin Pumps Market, France, Volume (Units), 2021-2025 31

Table 20: Insulin Delivery Market, France, Average Price ($), 2015-2020 32

Table 21: Insulin Delivery Market, France, Average Price ($), 2021-2025 32

Table 22: Insulin Delivery Market, France, Distribution Share by Revenue ($m), USD Constant, 2019 33

Table 23: Insulin Delivery Market, France, Company Share by Revenue ($m), USD Constant, 2019 35

Table 24: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, 2015-2020 37

Table 25: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, 2021-2025 37

Table 26: Insulin Pens Market, Germany, Revenue ($m), USD Constant, 2015-2020 39

Table 27: Insulin Pens Market, Germany, Revenue ($m), USD Constant, 2021-2025 39

Table 28: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, 2015-2020 41

Table 29: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, 2021-2025 41

Table 30: Insulin Delivery Market, Germany, Volume (Units), 2015-2020 43

Table 31: Insulin Delivery Market, Germany, Volume (Units), 2021-2025 43

Table 32: Insulin Pens Market, Germany, Volume (Units), 2015-2020 45

Table 33: Insulin Pens Market, Germany, Volume (Units), 2021-2025 45

Table 34: Insulin Pumps Market, Germany, Volume (Units), 2015-2020 47

Table 35: Insulin Pumps Market, Germany, Volume (Units), 2021-2025 47

Table 36: Insulin Delivery Market, Germany, Average Price ($), 2015-2020 48

Table 37: Insulin Delivery Market, Germany, Average Price ($), 2021-2025 48

Table 38: Insulin Delivery Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2019 49

Table 39: Insulin Delivery Market, Germany, Company Share by Revenue ($m), USD Constant, 2019 51

Table 40: Insulin Delivery Market, Italy, Revenue ($m), USD Constant, 2015-2020 53

Table 41: Insulin Delivery Market, Italy, Revenue ($m), USD Constant, 2021-2025 53

Table 42: Insulin Pens Market, Italy, Revenue ($m), USD Constant, 2015-2020 55

Table 43: Insulin Pens Market, Italy, Revenue ($m), USD Constant, 2021-2025 55

Table 44: Insulin Pumps Market, Italy, Revenue ($m), USD Constant, 2015-2020 57

Table 45: Insulin Pumps Market, Italy, Revenue ($m), USD Constant, 2021-2025 57

Table 46: Insulin Delivery Market, Italy, Volume (Units), 2015-2020 59

Table 47: Insulin Delivery Market, Italy, Volume (Units), 2021-2025 59

Table 48: Insulin Pens Market, Italy, Volume (Units), 2015-2020 61

Table 49: Insulin Pens Market, Italy, Volume (Units), 2021-2025 61

Table 50: Insulin Pumps Market, Italy, Volume (Units), 2015-2020 63

Table 51: Insulin Pumps Market, Italy, Volume (Units), 2021-2025 63

Table 52: Insulin Delivery Market, Italy, Average Price ($), 2015-2020 64

Table 53: Insulin Delivery Market, Italy, Average Price ($), 2021-2025 64

Table 54: Insulin Delivery Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2019 65

Table 55: Insulin Delivery Market, Italy, Company Share by Revenue ($m), USD Constant, 2019 67

Table 56: Insulin Delivery Market, Spain, Revenue ($m), USD Constant, 2015-2020 69

Table 57: Insulin Delivery Market, Spain, Revenue ($m), USD Constant, 2021-2025 69

Table 58: Insulin Pens Market, Spain, Revenue ($m), USD Constant, 2015-2020 71

Table 59: Insulin Pens Market, Spain, Revenue ($m), USD Constant, 2021-2025 71

Table 60: Insulin Pumps Market, Spain, Revenue ($m), USD Constant, 2015-2020 73

Table 61: Insulin Pumps Market, Spain, Revenue ($m), USD Constant, 2021-2025 73

Table 62: Insulin Delivery Market, Spain, Volume (Units), 2015-2020 75

Table 63: Insulin Delivery Market, Spain, Volume (Units), 2021-2025 75

Table 64: Insulin Pens Market, Spain, Volume (Units), 2015-2020 77

Table 65: Insulin Pens Market, Spain, Volume (Units), 2021-2025 77

Table 66: Insulin Pumps Market, Spain, Volume (Units), 2015-2020 79

Table 67: Insulin Pumps Market, Spain, Volume (Units), 2021-2025 79

Table 68: Insulin Delivery Market, Spain, Average Price ($), 2015-2020 80

Table 69: Insulin Delivery Market, Spain, Average Price ($), 2021-2025 80

Table 70: Insulin Delivery Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2019 81

Table 71: Insulin Delivery Market, Spain, Company Share by Revenue ($m), USD Constant, 2019 83

Table 72: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 85

Table 73: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 85

Table 74: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 87

Table 75: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 87

Table 76: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020 89

Table 77: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025 89

Table 78: Insulin Delivery Market, United Kingdom, Volume (Units), 2015-2020 91

Table 79: Insulin Delivery Market, United Kingdom, Volume (Units), 2021-2025 91

Table 80: Insulin Pens Market, United Kingdom, Volume (Units), 2015-2020 93

Table 81: Insulin Pens Market, United Kingdom, Volume (Units), 2021-2025 93

Table 82: Insulin Pumps Market, United Kingdom, Volume (Units), 2015-2020 95

Table 83: Insulin Pumps Market, United Kingdom, Volume (Units), 2021-2025 95

Table 84: Insulin Delivery Market, United Kingdom, Average Price ($), 2015-2020 96

Table 85: Insulin Delivery Market, United Kingdom, Average Price ($), 2021-2025 96

Table 86: Insulin Delivery Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2019 97

Table 87: Insulin Delivery Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2019 99

Table 88: Insulin Delivery Market Pipeline Products 102

Figures

1.2 List of Figures

Figure 1: Insulin Delivery Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2015-2025 10

Figure 2: Insulin Delivery Market, EU5, Revenue ($m), Historic, USD Constant, 2015-2025 12

Figure 3: Insulin Delivery Market, EU5, Volume (Units), 2015-2025 14

Figure 4: Insulin Delivery Market, EU5, Volume (Units), 2015-2025 16

Figure 5: Insulin Delivery Market, EU5, Company Share (%) 2019 18

Figure 6: Insulin Delivery Market, France, Revenue ($m), USD Constant, 2015-2025 20

Figure 7: Insulin Pens Market, France, Revenue ($m), USD Constant, 2015-2025 22

Figure 8: Insulin Pumps Market, France, Revenue ($m), USD Constant, 2015-2025 24

Figure 9: Insulin Delivery Market, France, Volume (Units), 2015-2025 26

Figure 10: Insulin Pens Market, France, Volume (Units), 2015-2025 28

Figure 11: Insulin Pumps Market, France, Volume (Units), 2015-2025 30

Figure 12: Insulin Delivery Market, France, Company Share (%) 2019 34

Figure 13: Insulin Delivery Market, Germany, Revenue ($m), USD Constant, 2015-2025 36

Figure 14: Insulin Pens Market, Germany, Revenue ($m), USD Constant, 2015-2025 38

Figure 15: Insulin Pumps Market, Germany, Revenue ($m), USD Constant, 2015-2025 40

Figure 16: Insulin Delivery Market, Germany, Volume (Units), 2015-2025 42

Figure 17: Insulin Pens Market, Germany, Volume (Units), 2015-2025 44

Figure 18: Insulin Pumps Market, Germany, Volume (Units), 2015-2025 46

Figure 19: Insulin Delivery Market, Germany, Company Share (%) 2019 50

Figure 20: Insulin Delivery Market, Italy, Revenue ($m), USD Constant, 2015-2025 52

Figure 21: Insulin Pens Market, Italy, Revenue ($m), USD Constant, 2015-2025 54

Figure 22: Insulin Pumps Market, Italy, Revenue ($m), USD Constant, 2015-2025 56

Figure 23: Insulin Delivery Market, Italy, Volume (Units), 2015-2025 58

Figure 24: Insulin Pens Market, Italy, Volume (Units), 2015-2025 60

Figure 25: Insulin Pumps Market, Italy, Volume (Units), 2015-2025 62

Figure 26: Insulin Delivery Market, Italy, Company Share (%) 2019 66

Figure 27: Insulin Delivery Market, Spain, Revenue ($m), USD Constant, 2015-2025 68

Figure 28: Insulin Pens Market, Spain, Revenue ($m), USD Constant, 2015-2025 70

Figure 29: Insulin Pumps Market, Spain, Revenue ($m), USD Constant, 2015-2025 72

Figure 30: Insulin Delivery Market, Spain, Volume (Units), 2015-2025 74

Figure 31: Insulin Pens Market, Spain, Volume (Units), 2015-2025 76

Figure 32: Insulin Pumps Market, Spain, Volume (Units), 2015-2025 78

Figure 33: Insulin Delivery Market, Spain, Company Share (%) 2019 82

Figure 34: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 84

Figure 35: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 86

Figure 36: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025 88

Figure 37: Insulin Delivery Market, United Kingdom, Volume (Units), 2015-2025 90

Figure 38: Insulin Pens Market, United Kingdom, Volume (Units), 2015-2025 92

Figure 39: Insulin Pumps Market, United Kingdom, Volume (Units), 2015-2025 94

Figure 40: Insulin Delivery Market, United Kingdom, Company Share (%) 2019 98

Frequently asked questions

EU5 Insulin Delivery Market Outlook to 2025 standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Diabetes Care Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at EU5 Insulin Delivery Market Outlook to 2025 in real time.

  • Access a live EU5 Insulin Delivery Market Outlook to 2025 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more